I'm going to tangent slightly, if I may.
Az, we know, is being sold at cost. I can see that, if you're baking buns, working out the cost per bun is fairly simple. We know that vaccine manufacture is more complicated.
We know vaccine is made in batches, with each batch having an unpredictable yield. Presumably costs per batch are relatively consistent. Your electricity, heating, rent costs are going to all be per hour. So will your staffing costs. You're going to pay the same ground rent no matter how productive your bubbling green* bottle of vaccine-stuff is. Bottling costs will be per dose, but a lot of the fixed costs will be relatively static per batch, I would have thought?
That means that, if a batch produces 50,000 doses, then each doses share of fixed costs is twice what it would be if it churned out 100,000. (Made up numbers - I have no idea what the real yield is.)
We know already that Az's estimates on how much each batch would produce are higher than what has happened. Presumably that means that the cost per dose is lower than it's turned out to be?
In addition, I suspect they've spent a fortune on lawyers in the past few weeks. Plus the costs of storing the Halix output in fridges for who knows how long.
So I'm guessing, right now, Az are running at a big loss on this.
I know there's provision in the Az/EU contract for Az to effectively demand more money if it isn't breaking even. I can see that going down like a lead balloon right now!
Does anyone have any information/insight on this aspect of things and how it's playing out in reality?
(*If it's neither green nor bubbling then please don't tell me. I have images of disney-esque mad scientists stroking their luminous testtubs and cackling, and I don't want my illusions burst.)